MELANOCYTE-STIMULATING HORMONE AND PARKINSONISM: THE ROLE OF HYPOTHALAMIC RELEASING FACTORS
- 17 March 1973
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 301 (7803) , 612
- https://doi.org/10.1016/s0140-6736(73)90765-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- EFFECTS OF THYROTROPIN-RELEASING HORMONE IN DEPRESSION*1The Lancet, 1972
- Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic HormoneScience, 1972
- IMPROVEMENT IN MENTAL DEPRESSION WITH DECREASED THYROTROPIN RESPONSE AFTER ADMINISTRATION OF THYROTROPIN-RELEASING HORMONEThe Lancet, 1972
- Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF)Experimental Biology and Medicine, 1972
- Gas chromatographic assay of picomole concentrations of biogenic aminesAnalytical Biochemistry, 1972
- Gas chromatographic assay of phenolic alcohols in biological material using electron capture detectionBiochemical Medicine, 1971
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971
- Further observations on the gas-chromatographic measurement of urinary phenolic and indolic metabolitesClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Gas chromatographic measurement of phenolic acids and alcohols in human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1968
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967